ELSID - Evaluation of a Large Scale Implementation of Disease Management Programmes for patients with type 2 diabetes

ELSID - Evaluation of a Large Scale Implementation of Disease Management Programmes for patients with type 2 diabete: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN08471887

Enrollment

4000

Registered

2005-07-20

Start date

2005-08-01

Completion date

Unknown

Last updated

2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Nutritional, Metabolic, Endocrine Diabetes

Interventions

Randomisation between DMP 1 and DMP 2. GPs in the DMP 1 group will offer regular consultations at 3- or 6-month intervals including detailed diabetes-specific anamnesis, physical examination includin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Control group: Practices and patients with type 2 diabetes not participating in a Diabetes-Disease Management Programme DMP 1 and DMP 2 group: Practices and patients with type 2 diabetes participating in a Diabetes-Disease Management Programme

Exclusion criteria

Exclusion criteria: Control group: Practices or Patients participating in any Disease Management Programmes

Design outcomes

Primary

Measure	Time frame
HbA1c and blood pressure.	—

Secondary

Measure	Time frame
Prescriptions, hospitalizations, referrals, severe complications, SCORE risk chart.	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026